PlainMeds rankings

Most FDA recall entries by listed makers

FDA Enforcement Report entries joined to the medicine, from the first entry in the report (2007) to 2026, counting only recalls by firms listed as its makers in FDA's NDC Directory or holding its application in Drugs@FDA. The most: levothyroxine (128 recall entries).

The ranking

Rank	Medicine	Recall entries
1	Levothyroxine0 Class I · 2 by other firms	128
2	Fentanyl10 Class I · 69 by other firms	111
3	Phenylephrine10 Class I · 22 by other firms	90
4	Losartan0 Class I	77
5	Sodium chloride16 Class I · 13 by other firms	77
6	Testosterone1 Class I · 150 by other firms	70
7	Morphine8 Class I · 79 by other firms	66
8	Metformin1 Class I · 1 by other firms	61
9	Estradiol0 Class I · 69 by other firms	60
10	Valsartan0 Class I · 4 by other firms	58
11	Duloxetine0 Class I · 1 by other firms	56
12	Methylphenidate0 Class I	55
13	Atorvastatin0 Class I	53
14	Vancomycin11 Class I · 47 by other firms	49
15	Norepinephrine1 Class I · 7 by other firms	47
16	Ranitidine0 Class I · 2 by other firms	47
17	Methylprednisolone6 Class I · 26 by other firms	46
18	Oxytocin2 Class I · 27 by other firms	43
19	Ibuprofen1 Class I	40
20	Lidocaine10 Class I · 24 by other firms	39
21	Metoprolol0 Class I · 1 by other firms	39
22	Bupropion0 Class I · 3 by other firms	35
23	Amlodipine0 Class I	30
24	Chlorhexidine and isopropyl alcohol9 Class I	30
25	Hydromorphone4 Class I · 85 by other firms	30
26	Succinylcholine0 Class I · 9 by other firms	30
27	Diltiazem0 Class I · 10 by other firms	29
28	Epinephrine8 Class I · 12 by other firms	29
29	Hydrochlorothiazide and losartan0 Class I	29
30	Cinacalcet0 Class I · 2 by other firms	28
31	Lisinopril0 Class I · 4 by other firms	28
32	Glycopyrrolate1 Class I · 18 by other firms	27
33	Triamcinolone0 Class I · 15 by other firms	27
34	Simvastatin0 Class I · 3 by other firms	26
35	Aripiprazole0 Class I · 2 by other firms	25
36	Chlorpromazine0 Class I · 3 by other firms	25
37	Pantoprazole1 Class I · 1 by other firms	25
38	Clindamycin0 Class I · 7 by other firms	24
39	Dextroamphetamine1 Class I	24
40	Ketorolac3 Class I · 2 by other firms	24
41	Potassium chloride8 Class I · 5 by other firms	24
42	Alprazolam0 Class I	23
43	Amphetamine and dextroamphetamine0 Class I	23
44	Hydrochlorothiazide and valsartan0 Class I	23
45	Carvedilol0 Class I · 1 by other firms	22
46	Cephalexin0 Class I	22
47	Gabapentin0 Class I	22
48	Fexofenadine0 Class I · 4 by other firms	21
49	Venlafaxine1 Class I · 6 by other firms	21
50	Albuterol1 Class I · 10 by other firms	20
51	Amlodipine and valsartan0 Class I	20
52	Ceftriaxone4 Class I · 7 by other firms	20
53	Ephedrine0 Class I · 7 by other firms	20
54	Timolol0 Class I	20
55	Acetaminophen3 Class I · 30 by other firms	19
56	Cetirizine1 Class I	19
57	Dextrose6 Class I	19
58	Doxycycline0 Class I · 3 by other firms	19
59	Glimepiride0 Class I · 1 by other firms	19
60	Midazolam4 Class I · 10 by other firms	19

Source: FDA Enforcement Report via openFDA, read October 8, 2026

What it cannot show

An entry covers specific products and lots; widely made medicines have more makers and so more entries. Recalls by compounding pharmacies and other firms that are not its listed makers are shown beside the count, not in it.